Literature DB >> 4816461

Neuraminidase activity in Streptococcus sanguis and in the viridans group, and occurrence of acylneuraminate lyase in viridans organisms isolated from patients with septicemia.

H E Müller.   

Abstract

The enzyme neuraminidase (EC 3.2.1.18) was found to be strongly active in different types of Streptococcus sanguis and S. viridans, and, in addition, the occurrence of the enzyme acylneuraminate pyruvate lyase (EC 4.1.3.3) was described in S. viridans. The enzyme-active bacteria strains were isolated from blood cultures of patients with septicemia. Whereas S. sanguis lost its strong neuraminidase activity after some weeks, S. viridans retained its enzyme activity for a long time in culture. Immunoelectrophoretic studies of the blood cultures of patients with streptococcal infections showed the loss of neuraminic acid in most glycoproteins of the serum, proving the in vivo action of neuraminidase. The pathogenic role of neuraminidase is discussed in streptococcal septicemia from the viewpoint of present knowledge.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4816461      PMCID: PMC414804          DOI: 10.1128/iai.9.2.323-328.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Toxicity of pneumococcal neuraminidase.

Authors:  R Kelly; D Greiff
Journal:  Infect Immun       Date:  1970-07       Impact factor: 3.441

2.  [Neuraminidase as a pathogenic factor in gas gangrene infections with Clostridium perfringens].

Authors:  H E Müller
Journal:  Dtsch Med Wochenschr       Date:  1970-03-06       Impact factor: 0.628

3.  [Severe pneumonia with hemolysis caused by neuraminidase. Detection of cryptantigens by indirect immunofluorescent technic].

Authors:  K Fischer; A Poschmann; H Oster
Journal:  Monatsschr Kinderheilkd       Date:  1971-01

4.  Streptococcal sialidase. II. Kinetic and immunological studies of sialidase produced by group K streptococcus.

Authors:  S Hayano; A Tanaka
Journal:  J Bacteriol       Date:  1968-05       Impact factor: 3.490

5.  [Neuraminidase as a pathogenetic factor in an abscess caused by Bacteroides fragilis].

Authors:  H E Müller; H Werner
Journal:  Z Med Mikrobiol Immunol       Date:  1970

6.  Carbohydrate hydrolases of oral streptococci.

Authors:  J K Pinter; J A Hayashi; A N Bahn
Journal:  Arch Oral Biol       Date:  1969-07       Impact factor: 2.633

7.  [Occurrence of neuraminidase in Corynebacterium acnes].

Authors:  H E Müller
Journal:  Z Med Mikrobiol Immunol       Date:  1971

8.  [A method for in vitro studies on the degradation of human plasma proteins by bacterial proteases using Pseudomonas aeruginosa as an example].

Authors:  H E Müller
Journal:  Zentralbl Bakteriol Orig       Date:  1971

9.  Distribution and serological specificity of sialidase produced by various groups of streptococci.

Authors:  S Hayano; A Tanaka; Y Okuyama
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

10.  Streptococcal sialidase. I. Isolation and properties of sialidase produced by group K Streptococcus.

Authors:  S Hayano; A Tanaka
Journal:  J Bacteriol       Date:  1967-06       Impact factor: 3.490

View more
  4 in total

1.  Production of extracellular material by streptococci associated with subacute bacterial endocarditis.

Authors:  D C Straus; S J Mattingly; T W Milligan
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

2.  Proteolytic action of Legionella pneumophila on human serum proteins.

Authors:  H E Müller
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

3.  The protection of mice by a specific anti-Erysipelothrix insidiosa-neuraminidase-antiserum against Erysipelothrix insidiosa infection.

Authors:  H E Müller
Journal:  Med Microbiol Immunol       Date:  1974-06-19       Impact factor: 3.402

4.  Neuraminidase production by a Streptococcus sanguis strain associated with subacute bacterial endocarditis.

Authors:  D C Straus; C Portnoy-Duran
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.